Skip to main content
Clinical Trials/IRCT20141009019470N72
IRCT20141009019470N72Not yet recruitingPhase 2

The effect of melatonin on interleukin 6 & interleukin 9 in coronary artery bypass grafting surgery

Shiraz University of Medical Sciences0 sites42 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
42

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Patients who are candidate for elective CABG
  • age between 40-75 years old
  • ASA class pump time less than 90 min;
  • graft number between 2 to 6

Exclusion Criteria

  • local or systemic infection
  • hyper sensitivity
  • redo surgery
  • surgery during last 6 months
  • collagen vascular disease
  • immunosuppressive disease
  • heart failure with ejection fraction less than 35%
  • recent cardiovascular event
  • renal failure
  • alcohol abuser
  • simultaneously valvular heart surgery
  • uncontrolled HTN
  • liver failure
  • breast feeding

Investigators

Similar Trials